HC Wainwright Reaffirms Buy Rating for Liquidia (NASDAQ:LQDA)
Liquidia (NASDAQ:LQDA – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a ...
HC Wainwright Has Bullish Forecast for Agenus Q1 Earnings
Investment analysts at HC Wainwright increased their Q1 2025 earnings per share (EPS) estimates for Agenus in a research note ...
Fintel on MSN8h
HC Wainwright & Co. Downgrades OptiNose (OPTN)
Fintel reports that on March 21, 2025, HC Wainwright & Co. downgraded their outlook for OptiNose (NasdaqGS:OPTN) from Buy to ...
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Elevation Oncology (ELEV) to $1 from $6 and keeps a Buy rating on the shares after the ...
Y-mAbs Therapeutics price target lowered to $12 from $22 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Y-mAbs Therapeutics (YMAB) to $12 from $22 and keeps a Buy rating on the shares. The firm is ...
Femasys price target raised to $15 from $12 at H.C. Wainwright
H.C. Wainwright analyst Emily Bodnar raised the firm’s price target on Femasys (FEMY) to $15 from $12 and keeps a Buy rating ...
Stocktwits on MSN10d
Core Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely Bullish
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours trading after analysts at HC Wainwright reiterated their rating for the stock.
Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference: ...
CoinDesk10d
U.S. Strategic Bitcoin Reserve a 'Monumental Endorsement' of the Crypto: H.C. Wainwright
The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...
H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)
Detailed price information for Actinium Pharmaceuticals Inc (ATNM-A) from The Globe and Mail including charting and trades.
H.C. Wainwright Sticks to Their Hold Rating for Biotricity (BTCY)
In a report released today, Kevin Dede from H.C. Wainwright maintained a Hold rating on Biotricity (BTCY – Research Report). The company’s shares closed last Friday at $0.50.